An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels

Thies Rösner, Stefanie Derer*, Christian Kellner, Michael Dechant, Stefan Lohse, Gestur Vidarsson, Matthias Peipp, Thomas Valerius

*Corresponding author for this work
    18 Citations (Scopus)
    Original languageEnglish
    JournalBritish Journal of Haematology
    Issue number2
    Pages (from-to)282-286
    Number of pages5
    Publication statusPublished - 04.2013

    Research Areas and Centers

    • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

    Cite this